AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FUROSEMIDE 40 Mg ;
10 registrations across 1 African market— 10 active
Markets with FUROSEMIDE 40 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Lasiphar 40 mg /4 ml solution for I.M / slow IV injection or IV infusion | 🇪🇬Egypt | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Furosemide 40 mg / 4 ml USP 2025 Solution For I.M or I.V. Injection | 🇪🇬Egypt | South Egypt Drug Industries Co (SEDICO) | active | — |
| Lasix ® Tablets | 🇪🇬Egypt | Sanofi Egypt | active | — |
| Lasiphar 40 mg /4 ml solution for I.M / slow IV injection or IV infusion | 🇪🇬Egypt | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Lafurex ®40 mg /4ml solution for I.M / slow IV injection or IV infusion | 🇪🇬Egypt | Amoun Pharmaceutical Company | active | — |
| Furosemide -Biocapital for Pharmaceutical & Chemical Industries sterile solution for IM , slow IV injection or infusion | 🇪🇬Egypt | Biocapital for Pharmaceutical and Chemical Industries | active | — |
| Furosemide 40 mg / 4 ml USP 2025 Solution For I.M or I.V. Injection | 🇪🇬Egypt | South Egypt Drug Industries Co (SEDICO) | active | — |
| Furosemide -Biocapital for Pharmaceutical & Chemical Industries sterile solution for IM , slow IV injection or infusion | 🇪🇬Egypt | Biocapital for Pharmaceutical and Chemical Industries | active | — |
| Lafurex ®40 mg /4ml solution for I.M / slow IV injection or IV infusion | 🇪🇬Egypt | Amoun Pharmaceutical Company | active | — |
| Lasix ® Tablets | 🇪🇬Egypt | Sanofi Egypt | active | — |
FUROSEMIDE 40 Mg ; in Africa — Regulatory Overview
FUROSEMIDE 40 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.